Drugs / Grippol Quadri
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03849560 | Nov 2016 → Jun 2017 | influenza | NPO Petrovax | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Grippol Quadri | “A Multicenter, Double-Blind, Randomized, Parallel Group Study of Safety, Reactogenicity, Immunogenicity, and Efficacy of Quadrivalent Influenza Vaccine Grippol Quadri and...” NCT03849560 ↗ |
| Modality | Vaccine | “Grippol® Quadri, a quadrivalent inactivated subunit influenza vaccine.” NCT03849560 ↗ |
| Route | Intramuscular | “Single intramuscular injection of 0.5 ml (1 dose) of vaccine Grippol® Quadri” NCT03849560 ↗ |